![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, November 03, 2011 4:40:50 PM
Seeing the articles being published in well-respected magazines, i tend to believe one day (not necessarily in the "near" future or term) they might get some approval, but... obvious risks are:
-approval is granted for (-again-) a limited use of the product, as I seem to understand from their apparently latest most up-to-date application with FDA (things being confused, not clearly worded in their various updates etc...)
-management runs this completely into the ground before clearance, what with blatant dilution going on recently and all
From my previous posts, it is very clear that I may believe in the product, but that I am utterly sad to see this operation being so poorly managed. As an investor/owner of this company it is my right to voice my serious concerns about mismanagement and to inform fellow shareholders, in the interest of the company and (our/your) shareholders value.
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM
Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM
Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM
POET Technologies Reports Second Quarter 2024 Financial Results • POET • Aug 15, 2024 8:04 AM